Angiogenic inhibition for the treatment of head and neck cancer

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2607-2609

  Gleich, Lyon L ^a   Zimmerman, Nives ^a   Wang, Ya Oin Lixin ^a   Gluckman, Jack L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Head and neck cancer; Nude mice; Squamous cell carcinoma; TNP 470

Indexed keywords

ANGIOGENESIS INHIBITOR; CYCLIN D1; FUMAGILLOL CHLOROACETYLCARBAMATE; MESSENGER RNA; PROTEIN P53;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; GENE MUTATION; HEAD CANCER; MOUSE; NECK CANCER; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYCLIN D1; CYCLOHEXANES; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; SESQUITERPENES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031839751     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. New Eng J Med 324: 1-7, 1991.
2. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
3. Petruzzelli GJ, Snyderman CH, Johnson JT, Myers EN: Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model. Ann Otol Rhinol Laryngol 102: 215-221, 1993.
4. Gleich LL, Biddinger PW, Pavelic ZP, Gluckman JL: Tumor angiogenesis in Tl oral cavity squamous cell carcinoma: Role in predicting tumor aggressiveness. Head Neck 18: 343-346, 1996.
5. Gleich LL, Biddinger PW, Duperier FD, Gluckman, JL: Tumor angiogenesis as a prognostic indicator in T2-4 oral cavity squamous cell carcinoma: A clinicalpathologic correlation. Head Neck 19: 276-280, 1997.
6. Folkman J: Tumor angiogenesis. Adv Cancer Res 43: 175-203, 1985.
7. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557, 1990.
8. Takamiya Y, Brem H, Ojeifo J, Mineta T, Martuza RL: AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurg 34: 869-875, 1994.
9. Takamiya Y, Friedlander RM, Brem H, Malick A, Martuza RL: Inhibition of angiogenesis and growth of human nerve sheath tumors by AGM-1470. J Neurosurg 78: 470-476, 1993.
10. Wang X, Pavelic ZP, Li Y-Q, Wang L, Gleich L, Radack K, Gluckman JL, Stambrook PJ: Amplification and overexpression ofthe cyclin Dl gene in head and neck squamous cell carcinoma. J Clin Pathol: Mol Pathol 48: M256-259, 1995.
11. Davis LG, Giber MD, Batte JF: Basic Methods in Molecular Biology. New York: Elsevier Science Publishing Co., Inc 1986: 130-135.
12. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996.
13. Hori A, Ikeyama S, Sudo K: Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem Biophys Res Commun 204: 1067-1073, 1994.